Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial.

住院 COVID-19 患者合併或未合併第二型糖尿病使用 dapagliflozin 之療效與安全性：DARE-19 隨機試驗的預先規劃分析